A/Prof Peter Foley
Associate Professor
Department of Medicine
379 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicentre, randomized, double-blinded, placebo-controlled trial.
DOI: 10.1093/bjd/ljag1092026
Journal article
73456 Patient-Level Persistence of On-Treatment Remission With Guselkumab: Pooled Results From VOYAGE 1 and VOYAGE 2 Participants With Moderate-to-Severe Plaque Psoriasis
DOI: 10.1016/j.jaad.2026.04.13192026
Journal article
Closing the Gap in Photoprotection: Implications for Skin of Colour in Australia
DOI: 10.1111/ajd.700542026
Journal article
Targeted Systemic Therapies for Atopic Dermatitis in Australia: A Narrative Review
DOI: 10.1111/ajd.700452026
Journal article
Hyperhidrosis: Diagnosis, assessment and stepwise management
2026
Journal article
Real-World Efficacy and Drug Survival of Adalimumab in Australian Patients With Psoriasis
DOI: 10.1111/ajd.700242019
Research Contracts
Salary Contribution - Ci Peter Foley 19/20 - Skin & Cancer Foundation Inc
RECENT SCHOLARLY WORKS
2026
Journal article
Long-Term Upadacitinib Safety in Moderate-to-Severe Atopic Dermatitis up to 7 Years: An Integrated Analysis With Over 9600 Patient-Years of Exposure
DOI: 10.25251/evafb1452026
Journal article
Topical therapies for psoriasis Selection, education, escalation of therapy
2026
Journal article
Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies
DOI: 10.1111/ajd.700022026
Journal article
Waiting for Access: How Bureaucracy Blocks Innovation in Australian Dermatology
DOI: 10.1111/ajd.70030